Dietary therapy for obesity: An emperor with no clothes

Hypertension

Volumn 51, Issue 6, 2008, Pages 1426-1434

  Mark, Allyn L ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; HYPOCHOLESTEROLEMIC AGENT; LEPTIN; MELANOCORTIN 4 RECEPTOR;

ADOPTION; APPETITE; BARIATRIC SURGERY; BEHAVIOR THERAPY; BODY WEIGHT; DIET THERAPY; ENERGY EXPENDITURE; ENVIRONMENTAL FACTOR; ENVIRONMENTAL STRESS; EPIGENETICS; ESSENTIAL HYPERTENSION; FOOD INTAKE; GENETIC RESISTANCE; GENOTYPE; HEREDITY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; METABOLISM; MUTATION; NEUROBIOLOGY; NONHUMAN; OBESITY; PARABIOSIS; PREGNANCY; PRIORITY JOURNAL; PUBLIC HEALTH; RELAPSE; REVIEW; TREATMENT INDICATION; TWINS; WEIGHT REDUCTION; ANIMAL; GENETICS; NOTE; PREVALENCE;

ANIMALS; HUMANS; HYPERTENSION; OBESITY; PREVALENCE;

EID: 45849087638     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.106.085944     Document Type: Review

References (62)

1. Keith SW, Redden DT, Katzmarzyk PT, Boggiano MM, Hanlon EC, Benca RM, Ruden D, Pietrobelli A, Barger JL, Fontaine KR, Wang C, Aronne LJ, Wright SM, Baskin M, Dhurandhar NV, Lijoii MC, Grilo CM, DeLuca M, Westfall AO, Allison DB. Putative contributors to the secular increase in obesity: exploring the roads less traveled. Int J Obesity. 2006;30:1585-1594.
2. Zhang Y, Poenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372:425-432.
3. Coleman DL. Effects of parabiosis of obese with diabetes and normal mice. Diabetologia. 1973;9:294-298.
4. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richard GJ, Campbfield LA, Clark FT, Deeds J, Muir C, Sanker S, Moriarty A, Moore KJ, Smutko JS, Mays GG, Wool EA, Monroe CA, Tepper RI. Identification and expression cloning of a leptin receptor, Ob-R. Cell. 1995;83:1263-1271.
5. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM. Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 1995;269:543-546.
6. Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ, Sewter CP, Digby JE, Mohammed SN, Hurst JA, Cheetham CH, Earley AR, Barnett AH, Prins JB, O'Rahilly S. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature. 1997;387:903-908.
7. Clement K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, Gourmelen M, Dina C, Chambaz J, Lacorte JM, Basdevant A, Bougneres P, Lebouc Y, Froguel P, Guy-Grand B. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature. 1998;392:398-401.
8. Farooqi IS, Wangensteen T, Collins S, Kimber W, Matarese G, Keogh JM, Lank E, Bottomley B, Lopez-Fernandez J, Ferraz-Amaro I, Dattani MT, Ercan O, Myhre AG, Retterstol L, Stanhope R, Edge JA, McKenzie S, LessanN, Ghodsi M, De Rosa V, Perna F, Fontana S, Barroso I, Undlien DE, O'Rahilly S. Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor. N Engl J Med. 2007;356:237-247.
9. Farooqi IS, Jebb SA, Langmack G, Lawrence E, Cheetham CH, Prentice AM, Hughes IA, McCamish MA, O'Rahilly S. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med.1999;341:879-884.
10. Yeo GSH, Farooqi IS, Aminian S, Halsall DJ, Stanhope RG, O'Rahilly S. A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nature Genetics. 1998;20:111-112.
11. Farooqi IS, Keogh JM, Yeo GSH, Lank EJ, Cheetham T, O'Rahilly S. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Eng J Med. 2003;348:1085-1095.
12. O'Rahilly S, Farooqi IS. Genetics of obesity. Phil Trans Royal Soc. 2006;361:1095-1105.
13. Stunkard AJ, Sorenson TIA, Hanis C, Teasdale TW, Chakraborty R, Schull WJ, Schulsinger F. An adoption study of human obesity. N Engl J Med. 1986;314:193-198.
14. Borjeson M. The aetiology of obesity in children: A study of 101 twin pairs. Acta Paediatrics Scand. 1976;65:279 -287.
15. Stunkard AJ, Foch TT, Hrubec Z. A twin study of human obesity. JAMA. 1986;256:51-54.
16. Stunkard AJ, Harris JR, Pedersen NL, McClearn GE. The body-mass index oftwins who have been reared apart. New Eng JMed. 1990;322:1483-1487.
17. Allison DB, Kaprio J, Korkeila M, Koskenvuo M, Neale MC, Hayakawa K. The hereditability of body mass index among an international sample of monozygotic twins reared apart. Int J Obesity. 1996;20:501-506.
18. Bouchard C, Tremblay A, Despres J-P, Nadeau A, Lupien PJ, Theriault G, Dussault J, Moorjani S, Pinault S, Fournier G. The response to long-term overfeeding in identical twins. N Engl J Med. 1990;322:1477-1482.
19. Levin BE, Triscari J, Sullivan AC. Relationship between sympathetic activity and diet-induced obesity in two strains of rats. Am J Physiol. 1983;245:R367-R371.
20. Levin BE, Dunn-Meynell AA. Defense of body weight against chronic caloric restriction in obesity-prone and -resistant rats. Am J Physiol. 2000;278:R231-R237.
21. Levin BE. The drive to regain is mainly in the brain. Am J Physiol. 2004;287:R1297-R1300.
22. Hill JO, Fried SK, DiGirolamo M. Effects of a high-fat diet on energy intake and expenditure in rats. Life Sciences. 1983;33:141-149.
23. Chang S, Graham B, Yakubu F, Lin D, Peters JC, Hill JO. Metabolic differences between obesity-prone and obesity-resistant rats. Am J Physiol. 1990;259:R1103-R1110.
24. MacLean PS. A peripheral perspective of weight regain. Am J Physiol.2005;288:R1447-R1449.
25. MacLean PS, Higgins JA, Jackman MR, Johnson GC, Fleming-Elder BK, Wyatt HR, Melanson EL, Hill JO. Peripheral metabolic responses to prolonged weight reduction that promote rapid, efficient regain in obesity-prone rats. Am J Physiol. 2006;290:R1577-R1588.
26. Sturm R. Increases in clinically severe obesity in the United States, 1986-2000. Arch Int Med. 2003;163:2146-2148.
27. Friedman JM. A war on obesity, not the obese. Science. 2003;299:856-858.
28. Levine JA, Eberhardt NL, Jensen MD. Role of nonexercise activity thermo- genesis in resistance to fat gain in humans. Science. 1999;283:212-214.
29. Bray GA, Champagne CM. Beyond energy balance: There is more to obesity than kilocalories. J Am Dietetic Assoc. 2005;105:S17-S23.
30. Levin BE. Metabolic imprinting: critical impact of the perinatal environment on the regulation of energy homeostasis. Phil Trans Royal Soc. 2006;361:1107-1121.
31. Barker DJ. The Wellcome Foundation Lecture, 1994. The fetal origins of adult disease. Proc Biol Sci. 1995;262:37-43.
32. Koza RA, Nikonova L, Hogan J, Rim J-S, Mendoza T, Faulk C, Skaf J, Kozak LP. Changes in gene expression foreshadow diet-induced obesity in genetically identical mice. PLoS Genetics. 2006;2:e81.
33. Dong C, Li W-D, Geller F, Lei L, Li D, Gorlova OY, Hebebrand J, Amos CI, Nicholls RD, Price RA. Possible genomic imprinting of three human obesity-related genetic loci. Am J Hum Genet. 2005;76:427-437.
34. Stunkard AJ. The managementofobesity. N Y State J Med. 1958;58:79-87.
35. Kramer FM, Jeffery RW, Forster JL, Snell MK. Long-term followup of behavioral treatment for obesity: Patterns of weight regain among men and women. Int J Obesity. 1989;13:123-126.
36. Rosenbaum MJ, Leibel RL, Hirsch J. Obesity. N Engl J Med. 1997;337: 396-407.
37. Dansinger ML, Tatsioni A, Wong JB, Balk EM. Meta-analysis: The effect of dietary counseling for weight loss. Ann Intern Med. 2007;147:41-50.
38. Wilfley DE, Stein RI, Saelens BE, Mockus DS, Matt GE, Hayden-Wade HA, Welch RR, Schlechtman KB, Epstein LH. Efficacy of maintenance treatment approaches for childhood overweight: A randomized controlled trial. JAMA. 2007;298:1661-1673.
39. Rhodes ET, Ludwig DS. Childhood obesity as a chronic disease: Keeping the weight off. JAMA. 2007;298:1695-1696.
40. Tsai AG, Wadden TA. Systematic review: An evaluation of major commercial weight loss programs in the United States. Ann Intern Med. 2005;142:56-66.
41. Hill JO. Understanding and addressing the epidemic of obesity: An energy balance perspective. Endocrine Reviews. 2006;27:750-761.
42. Klem ML, Wing RR, McGuire MT, Seagle HM, Hill JO. A descriptive study of individuals successful at long-term maintenance of substantial weight loss. Am J Clin Nutr. 1997;66:230-246.
43. Tate DF, Jeffery RW, Sherwood NE, Wing RR. Long-term weight losses associated with prescription of higher physical activity goals. Are higher levels of physical activity protective against weight regain? Am J Clin Nutr. 2007;85:954-959.
44. Weinberg N, Mendelson M, Stunkard A. A failure to find distinctive personality features ina groupofobese men. AmJPsych. 1961;117:1035-1037.
45. Friedman JF. Modern science versus the stigma of obesity. Nature Medicine. 2004;10:563-569.
46. Glucksman ML, Hirsch J. The response of obese patients to weight reduction: A clinical evaluation of behavior. Psychosomatic Medicine. 1968;30:1-11.
47. Hirsch J. Obesity: Matter over mind? Cerebrum: The Dana Forum on Science. 2003;5:7-18.
48. Leibel RL, Rosenbaum M, Hirsch J. Changes in energy expenditure resulting from altered body weight. N Engl J Med. 1995;332:621-628.
49. Dansinger ML, Gleason JA, Griffith JL, Selker HP, Schaefer EJ. Comparison of the Atkins, Ornish, Weight Watchers and Zone diets for weight loss and heart disease risk reduction: A randomized trial. JAMA. 2005; 293:43-53.
50. Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP, Purnell JO. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med. 2002;346:1623-1630.
51. Schwartz MW, Woods SC, Seeley RJ, Barsh GS, Baskin DG, Leibel RL. Is the energy homeostasis system inherently biased toward weight gain? Diabetes. 2003;52:232-238.
52. Berthoud H-R. Interactions between the "cognitive" and "metabolic"brain in the control of food intake. Physiol Behav. 2007;91:486-498.
53. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K. Bariatric surgery: A systematic review and meta-analysis. JAMA. 2004;292:1724-1737.
54. DeMaria EJ. Bariatric surgery for morbid obesity. N Engl J Med. 2007; 356:2176-2183.
55. Sjostrom L, Lindroos A-K, Peltonen M, Torgerson J, Bouchard C, Carlsson B, Dahlgren S, Larsson B, Narbro K, Sjostrom CD, Sullivan M, Wedel H for the Swedish Obese Subjects Study Group. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery.N Engl J Med. 2004;351:2683-2693.
56. Dixon JB, O'Brien PE, Playfair J, Chapman L, Schachter LM, Skinner S, Proietto J, Bailey M, Anderson M. Adjustable gastric banding and conventional therapy for type 2 diabetes: A randomized controlled trial. JAMA. 2008;299:316-323.
57. Sjostrom L, Narbro K, Sjostrom CD, Karason K, Larsson B, Wedel H, Lystig T, Sullivan M, Bouchard C, Carlsson B, Bengtsson C, Dahlgren S, Gummesson A, Jacobson P, Karlsson J, Lindroos AK, Lonroth H, Naslund I, Olbers T, Stenlof K, Torgerson J, Agren G, Carlsson LM; Swedish Obese Subjects Study. Effects of bariatric surgery on mortality in Swedish Obese Subjects. N Engl J Med. 2007;357:741-752.
58. Adams TD, Gress RE, Smith SC, Halversen RC, Simper SC, Rosamond WD, LaMonte MJ, Stroup AM, Hunt SC. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357:753-761.
59. Cummings DE, Flum DR. Gastrointestinal surgery as a treatment for diabetes. JAMA. 2008;299:341-343.
60. Sjostrom CD, Peltonen M, Wedel H, Sjostrom L. Differentiated long-term effects of intentional weight loss on diabetes and hypertension. Hypertension. 2000;36:20-25.
61. Roth JD, Coffey T, Jodka CM, Maier H, Athanacio JR, Mack CM, Weyer C, Parkes DG. Combination therapy with amylin and peptide YY [3-36] in obese rodents: Anorexigenic synergy and weight loss additivity.Endocrinology. 2007;148:6054-6061.
62. Roth JD, Roland B, Cole R, Coffey T, Cronister C, Weyer C, Baron A, Parkes D. Responsiveness to leptin restored by amylin in diet-induced obese (DIO) rats: Magnitude and mechanism of synergy. Diabetes. 2007;56:Suppl 1, A72.